Skip to main content
All lobbying filings

TODD STRATEGY GROUP

Lobbying for BRIDGEBIO PHARMA · Biopharmaceutical manufacturer.

 Filing 2nd Quarter - Termination
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Oct 11, 2025
Income
$20,000.00
What the client paid this registrant for the period.
Client based in
California
Representation ended
Jun 30, 2025
The registrant reported terminating its work for this client.

Official filing document

 Lobbyists on this filing 4
  • KATHERINE FLEMING COTTON
    Previously held: Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
  • PAUL EDATTEL
    Previously held: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
  • DANIEL M TODD
    Previously held: Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
  • NICHOLAS UEHLECKE
    Previously held: Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 3
  • Centers For Medicare and Medicaid Services (CMS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Pharmacy

PBM Policy Reform. Prior authorization. Utilization management.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem